The US military’s race to make fake blood

··7 min read
ScienceTechnologyHealth
Share𝕏inEmail

AI Summary

This newsletter from MIT Technology Review covers DARPA's $73 million project to develop shelf-stable dried blood products for military use, WeLion New Energy's semi-solid-state batteries as a climate tech to watch, and a podcast exploring whether GLP-1 weight-loss drugs can slow biological aging. It also includes a roundup of tech news stories.

Key Facts

✓DARPA is investing $73 million to develop shelf-stable dried blood products for battlefield use.
✓WeLion New Energy's semi-solid-state batteries can power EVs for over 1,000 km and aim for even higher energy density.
✓GLP-1 drugs from Eli Lilly and Novo Nordisk may slow biological aging, according to drugmakers.

Related

📰Briefing📈Intelligence📚Library